DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kamm MA, Lichtenstein GR, Sandborn WJ. et al.
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.
Gut 2008;
57: 893-902
We do not assume any responsibility for the contents of the web pages of other providers.